Montelukast and Acute Coronary Syndrome: The Endowed Drug

Montelukast and Acute Coronary Syndrome: The Endowed Drug

Acute coronary syndrome (ACS) is a set of signs and symptoms caused by a reduction of coronary blood flow with subsequent myocardial ischemia. ACS is associated with activation of the leukotriene (LT) pathway with subsequent releases of various LTs, including LTB4, LTC4, and LTD4, which cause inflam...

Full description

Bibliographic Details
Main Authors: Basil Mohammed Alomair, Hayder M. Al-kuraishy, Ali I. Al-Gareeb, Sadiq M. Al-Hamash, Michel De Waard, Jean-Marc Sabatier, Hebatallah M. Saad, Gaber El-Saber Batiha
Format: Article
Language:English
Published: MDPI AG 2022-09-01
Series:Pharmaceuticals
Subjects:
acute coronary syndrome
leukotriene
montelukast
antileukotrienes therapy
Online Access:https://www.mdpi.com/1424-8247/15/9/1147

Internet

https://www.mdpi.com/1424-8247/15/9/1147

Similar Items